Literature DB >> 21590263

Reply to the correspondence letter by Dr. Mitra S. to "alendronate for the treatment of hypercalcaemia due to neonatal subcutaneous fat necrosis".

Nilay Hakan, Mustafa Aydin, Ayşegul Zenciroglu.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21590263     DOI： 10.1007/s00431-011-1494-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  6 in total

1.  Alendronate for the treatment of hypercalcaemia due to neonatal subcutaneous fat necrosis.

Authors:  Nilay Hakan; Mustafa Aydin; Ayşegul Zenciroglu; Nihal Demirel; Nurullah Okumus; Semra Cetinkaya; Mehmet Sah Ipek
Journal:  Eur J Pediatr       Date:  2011-04-13       Impact factor: 3.183

2.  Reply to the correspondence letter by Dr. Mitra S. to "alendronate for the treatment of hypercalcaemia due to neonatal subcutaneous fat necrosis".

Authors:  Nilay Hakan; Mustafa Aydin; Ayşegul Zenciroglu
Journal:  Eur J Pediatr       Date:  2011-05-18       Impact factor: 3.183

3.  Efficacy of oral alendronate in children with osteogenesis imperfecta.

Authors:  Tae-Joon Cho; In Ho Choi; Chin Youb Chung; Won Joon Yoo; Moon Seok Park; Yong Koo Park
Journal:  J Pediatr Orthop       Date:  2005 Sep-Oct       Impact factor: 2.324

4.  Pharmacokinetics of alendronate: an overview.

Authors:  J H Lin; G Russell; B Gertz
Journal:  Int J Clin Pract Suppl       Date:  1999-04

Review 5.  Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

6.  Intragastric alendronate therapy in two infants with vitamin D intoxication: a new method.

Authors:  Hakan Doneray; Behzat Ozkan; Ibrahim Caner; Asuman Ozkan; Cahit Karakelleoglu
Journal:  Clin Toxicol (Phila)       Date:  2008-04       Impact factor: 4.467
  6 in total
  1 in total

1.  Reply to the correspondence letter by Dr. Mitra S. to "alendronate for the treatment of hypercalcaemia due to neonatal subcutaneous fat necrosis".

Authors:  Nilay Hakan; Mustafa Aydin; Ayşegul Zenciroglu
Journal:  Eur J Pediatr       Date:  2011-05-18       Impact factor: 3.183
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.